| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 35.44B | 37.75B | 36.57B | 34.08B | 31.68B |
| Gross Profit | 18.58B | 15.80B | 16.96B | 34.08B | 31.68B |
| EBITDA | 21.29B | 11.30B | 12.01B | 14.45B | 12.35B |
| Net Income | 3.79B | 3.89B | 6.30B | 6.38B | 5.90B |
Balance Sheet | |||||
| Total Assets | 371.12B | 360.39B | 351.48B | 346.99B | 335.88B |
| Cash, Cash Equivalents and Short-Term Investments | 25.35B | 34.20B | 22.07B | 19.67B | 19.63B |
| Total Debt | 269.01B | 265.91B | 256.62B | 251.83B | 230.81B |
| Total Liabilities | 309.97B | 302.91B | 293.91B | 294.55B | 282.83B |
| Stockholders Equity | 51.96B | 48.99B | 51.67B | 48.33B | 49.04B |
Cash Flow | |||||
| Free Cash Flow | -1.79B | 1.55B | 1.17B | -11.64B | -25.33B |
| Operating Cash Flow | 1.15B | 9.97B | 3.73B | -7.69B | -14.87B |
| Investing Cash Flow | -1.45B | -3.54B | -2.40B | -1.77B | -9.85B |
| Financing Cash Flow | 1.58B | -5.60B | 1.59B | 9.61B | 28.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$680.00M | 7.26 | 6.53% | 5.46% | -24.04% | 60.24% | |
71 Outperform | HK$6.84B | 5.14 | 5.14% | 11.28% | 0.59% | -5.95% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | HK$1.37B | 4.31 | 8.51% | 7.43% | 1.11% | 3.98% | |
59 Neutral | HK$270.55M | 20.00 | 1.09% | ― | 8.77% | -76.88% | |
56 Neutral | HK$18.71B | 2.09 | 12.27% | 5.84% | 3.17% | 23.13% | |
54 Neutral | HK$33.27B | 8.52 | 7.50% | 6.69% | -1.77% | -24.74% |